Malignant Peritoneal Neoplasm Recruiting Phase 3 Trials for Paclitaxel (DB01229)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04209855A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha ExpressionTreatment
NCT02855944ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PatientsTreatment
NCT03693248Reduction Of Cycles of neOadjuvant Chemotherapy for Advanced Epithelial Ovarian, Fallopian and Primary Peritoneal CancerTreatment